ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Medenica Granted Extension Of Privileges At Hilton Head Hospital

November 26, 1993

Spartanburg CCOP Makes the List

April 10, 1987

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978